HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The action of small doses of lead on erythrocyte D-aminolevulinic acid dehydratase in the mouse.

Abstract
After a single intraperitoneal administration of lead in very small doses [1--100 micrograms Pbac/kg body weight (bw)], there was a dose-dependent, highly significant inhibition of erythrocyte D-aminolevulinic acid dehydratase (D-ALA-D) activity in mice. The maximal inhibition occurred between 3 and 24 h post injection (p.i.). After that, a rapid recovery of the D-ALA-D activity took place so that four days after lead administration, enzyme activity exceeded even the normal value. Only after eight days p.i. did the D-ALA-D value return to the initial level after a biphasic course. After 10 i.p. injections of 0.1 to 10 micrograms Pbac/kg bw, there was again a dose-dependent, highly significant inhibition of the erythrocyte D-ALA-D activity in mice. The maximal inhibition was shown to be 24 h after the last lead injection. In contrast to the single i.p. administration, however, we found a monophasic course for the return of D-ALA-D activity. The D-ALA-D values did not exceed the normal range at any time after 10 i.p. lead injections. Ten and 30 days oral administration of lead corresponding to i.p. doses exhibited similar results in D-ALA-D inhibition.
AuthorsE Schlick, K D Friedberg
JournalArchives of toxicology (Arch Toxicol) Vol. 43 Issue 3 Pg. 213-20 (Jan 1980) ISSN: 0340-5761 [Print] Germany
PMID7369869 (Publication Type: Journal Article)
Chemical References
  • Lead
  • Porphobilinogen Synthase
Topics
  • Animals
  • Erythrocytes (enzymology)
  • Injections, Intraperitoneal
  • Lead (administration & dosage)
  • Lead Poisoning (enzymology)
  • Male
  • Mice
  • Porphobilinogen Synthase (blood)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: